Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica

2009

1. 1,3-Dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships

   Bioorganic and Medicinal Chemistry, Vol. 17, Núm. 10, pp. 3618-3629

2. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors

   Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 12, pp. 3268-3270

3. Advantages of neurofuzzy logic against conventional experimental design and statistical analysis in studying and developing direct compression formulations

   European Journal of Pharmaceutical Sciences, Vol. 38, Núm. 4, pp. 325-331

4. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors

   Molecular Pharmaceutics, Vol. 6, Núm. 3, pp. 825-835

5. Alkali and alkaline-earth metal complexes of different nuclearities with azamacrocyclic pendant-arms ligands

   Inorganica Chimica Acta, Vol. 362, Núm. 9, pp. 3351-3356

6. An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes

   Schizophrenia Research, Vol. 111, Núm. 1-3, pp. 115-122

7. Application of principal component analysis to the thermal characterization of silanized nanoparticles obtained at supercritical carbon dioxide conditions

   Analytica Chimica Acta, Vol. 635, Núm. 2, pp. 227-234

8. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis

   Human Pathology, Vol. 40, Núm. 10, pp. 1418-1426

9. Chapter 15 Mucosal Delivery of Liposome-Chitosan Nanoparticle Complexes

   Methods in Enzymology, Vol. 465, Núm. C, pp. 289-312

10. Chitosan nanoparticles for drug delivery to the eye

    Expert Opinion on Drug Delivery, Vol. 6, Núm. 3, pp. 239-253

11. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules

    Biomacromolecules, Vol. 10, Núm. 7, pp. 1736-1743

12. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma

    International Journal of Pharmaceutics, Vol. 381, Núm. 2, pp. 122-129

13. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 71, Núm. 2, pp. 257-263

14. Composite fibrous biomaterials for tissue engineering obtained using a supercritical CO2 antisolvent process

    Acta Biomaterialia, Vol. 5, Núm. 4, pp. 1094-1103

15. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response

    Journal of Drug Targeting, Vol. 17, Núm. 8, pp. 652-661

16. Cuantificación del estudio de perfusión miocárdica en pacientes con baja probabilidad de cardiopatía isquémica. Valores normales de gated-SPECT con 201Tl

    Revista Espanola de Medicina Nuclear, Vol. 28, Núm. 4, pp. 193-199

17. Cyclodextrin-functionalized polyethylene and polypropylene as biocompatible materials for diclofenac delivery

    International Journal of Pharmaceutics, Vol. 382, Núm. 1-2, pp. 183-191

18. Detection of Gymnodimine-A and 13-Desmethyl C spirolide phycotoxins by fluorescence polarization

    Analytical Chemistry, Vol. 81, Núm. 7, pp. 2708-2714

19. Development of granules from Phyllanthus niruri spray-dried extract

    Brazilian Journal of Pharmaceutical Sciences, Vol. 45, Núm. 4, pp. 669-675

20. Divergent solution-phase synthesis of diarylpyrimidine libraries as selective A3 adenosine receptor antagonists

    Journal of Combinatorial Chemistry, Vol. 11, Núm. 4, pp. 519-522